CAR-T Therapy Global Market Research Report 2022: Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, & Multiple Myeloma - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "CAR-T Therapy Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.

The global CAR-T therapy market is expected to grow from $1.40 billion in 2021 to $1.80 billion in 2022 at a compound annual growth rate (CAGR) of 28.6%. The market is expected to grow to $3.55 billion in 2026 at a compound annual growth rate (CAGR) of 18.5%.

CAR-T Therapy Global Market Report 2022 provides the strategists, marketers and senior management with the critical information they need to assess the global CAR-T therapy market.

Major players in the chimeric antigen receptor -T therapy market are Novartis AG, Kite Pharma, Pfizer Inc, Juno Therapeutics, Celgene Corporation, CARsgen Therapeutics, Sorrento Therapeutics, Legend Biotech, Mustang Bio, and Immune Therapeutics.

This report focuses on CAR-T therapy market which is experiencing strong growth. The report gives a guide to the CAR-T therapy market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Where is the largest and fastest growing market for the CAR-T therapy? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The CAR-T therapy market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider CAR-T therapy market, and compares it with other markets.

• The market characteristics section of the report defines and explains the market
• The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth
• Market segmentations break down market into sub markets
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets
• Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers
• The CAR-T therapy market section of the report gives context. It compares the CAR-T therapy market with other segments of the CAR-T therapy market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, CAR-T therapy indicators comparison

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates
• Create regional and country strategies on the basis of local data and analysis
• Identify growth segments for investment
• Outperform competitors using forecast data and the drivers and trends shaping the market
• Understand customers based on the latest market research findings
• Benchmark performance against key competitors
• Utilize the relationships between key data sets for superior strategizing
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Key Topics Covered:

1. Executive Summary

2. CAR-T Therapy Market Characteristics

3. CAR-T Therapy Market Trends And Strategies

4. Impact Of COVID-19 On CAR-T Therapy

5. CAR-T Therapy Market Size And Growth

5.1. Global CAR-T Therapy Historic Market, 2016-2021, $ Billion

5.1.1. Drivers Of The Market

5.1.2. Restraints On The Market

5.2. Global CAR-T Therapy Forecast Market, 2021-2026F, 2031F, $ Billion

5.2.1. Drivers Of The Market

5.2.2. Restraints On the Market

6. CAR-T Therapy Market Segmentation

6.1. Global CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

• Monotherapy
• Combination Therapy

6.2. Global CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

• CD19
• CD22
• Other Target Antigen

6.3. Global CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

• Acute Lymphoblastic Leukemia
• Diffuse Large B-Cell Lymphoma
• Follicular Lymphoma
• Chronic Lymphocytic Leukemia
• Multiple Myeloma
• Other Applications

7. CAR-T Therapy Market Regional And Country Analysis

7.1. Global CAR-T Therapy Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

7.2. Global CAR-T Therapy Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Companies Mentioned

• Novartis AG
• Kite Pharma
• Pfizer inc.
• Juno Therapeutics
• Celgene Corporation
• CARsgen Therapeutics
• Sorrento Therapeutics
• Legend Biotech
• Mustang Bio
• Immune Therapeutics
• Atara Biotherapeutics
• Aurora Biopharma Inc.
• Eureka Therapeutics
• Autolus
• TILT Biotherapeutics
• Fortress Biotech
• Autolus Therapeutics plc.
• bluebird bio
• Carina Biotech
• CARTherics
• Endocyte, Inc.
• F1 Oncology, Inc.
• Fate Therapeutics Inc.
• Gilead
• Oxford BioMedica PLC.
• PeproMene Bio Inc.
• Tessa Therapeutics Pte Ltd.
• TILT Biotherapeutics Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/jjgw5z